Attached files
| file | filename |
|---|---|
| EX-3.1 - EXHIBIT 3.1 - AIM ImmunoTech Inc. | ex31-amendrestatebylaws11x.htm |
| EX-10.1 - EXHIBIT 10.1 - AIM ImmunoTech Inc. | ex101-mytomorrowxredacted.htm |
| EX-32.2 - EXHIBIT 32.2 - AIM ImmunoTech Inc. | heb-20150930xex322.htm |
| EX-31.2 - EXHIBIT 31.2 - AIM ImmunoTech Inc. | heb-20150930xex312.htm |
| EX-10.2 - EXHIBIT 10.2 - AIM ImmunoTech Inc. | ex102-mytomorrowsaddeapxre.htm |
| EX-32.2 - EXHIBIT 32.2 - AIM ImmunoTech Inc. | heb-20150930xex321.htm |
| EX-31.1 - EXHIBIT 31.1 - AIM ImmunoTech Inc. | heb-20150930xex311.htm |
| 10-Q - 10-Q - AIM ImmunoTech Inc. | heb-2015093010q.htm |
Exhibit 10.3
September 28, 2015
William Mitchell, MD, PhD
Chairman Compensation Committee
Hemispherx Biopharma, Inc.
One Penn Center
1617 JFK Blvd.
Philadelphia, PA 19103
Dear Bill,
I understand that the Compensation Committee has initiated a review of my Hemispherx contracts and have discovered today an automatic extension in several days of my patent consulting contract. I agree with an extension to December 1, 2015 of the period of notice of non-renewal as provided in Section 2 of the Amended and Restated Engagement Agreement between Hemispherx Biopharma, Inc. and me entered into as of June 11, 2010.
I have indicated my agreement by my signature in the space provided below. Tom Equels will be with me later today. I will have him witness for Hemispherx and deliver to the Compensation Committee.
/s/ William A. Carter____________
William A. Carter, M.D.
Hemispherx Biopharma, Inc.
By: /s/ Thomas K. Equels_______
Thomas K. Equels, President